Skip to content

Adaptive Treatment Strategies for Improving Engagement With a Web-Based Smoking Intervention in Socially Anxious Smokers

A SMART Pilot of Adaptive Treatment Strategies to Improve Engagement With a Web-Based Intervention for Socially Anxious Smokers

Status
Withdrawn
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04260776
Enrollment
0
Registered
2020-02-07
Start date
2022-04-15
Completion date
2024-12-31
Last updated
2021-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Social Anxiety Disorder, Tobacco Use Disorder

Brief summary

This phase I trial will use a pilot sequential multiple assignment randomized trial (SMART) to examine protocol feasibility and acceptability of new components of a web-based intervention for socially anxious smokers. This study will be used to help build an adaptive treatment strategy to improve engagement with and effectiveness of the web-based intervention. Adaptive treatment strategies provide individualized sequences of intervention components to accommodate the changing needs of individuals based on their characteristics, treatment response, or engagement.

Detailed description

This study proposes to use a pilot SMART to help build an adaptive treatment strategy to improve engagement with and effectiveness of a web-based intervention for socially anxious smokers. At the outset of the study (Phase 1), participants will receive access to a new web-based smoking intervention (MyWebQuit) and will randomized to receive one of two text message services: 1) 1-way text messages, or 2) interactive, 2-way text messages. Those who disengage with the website in the first 5 weeks will be re-randomized to one of three re-engagement strategies: 1) re-engagement emails, 2) re-engagement interactive text messages, or 3) no re-engagement strategy. Outcomes include protocol feasibility, treatment acceptability, treatment utilization, and smoking cessation.

Interventions

BEHAVIORALPhase 1: Web-based intervention (MyWebQuit) with 1-way text messages

Participants will receive MyWebQuit (web-based smoking intervention) along with a corresponding 1-way text messages

BEHAVIORALPhase 1: Web-based intervention (MyWebQuit) with interactive, 2-way text messages

Participants will receive MyWebQuit (web-based smoking intervention) along with corresponding interactive, 2-way text messages

BEHAVIORALPhase 2: re-engagement text messages

In addition to Phase 1 intervention components, 1/3 of participants who disengage with the website will receive interactive text messages designed to promote re-engagement

BEHAVIORALPhase 2: re-engagement emails

In addition to Phase 1 intervention components, 1/3 of participants who disengage with the website will receive a personalized email designed to promote re-engagement

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
Fred Hutchinson Cancer Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* resides in the US and anticipates remaining in the US for the duration of the study * smokes at least 5 cigarettes per day for at least 12 months prior to screening * desire to quit smoking within 30 days * has at least weekly internet access * current use of a personal email account * current use of text messaging * willing to receive text messages as part of this study * screen positive for social anxiety (LSAS-SR ≥ 60) * interested in participating in the study for themselves (versus \[vs\] someone else) * not currently taking part in any other smoking cessation treatment such as the nicotine patch, nicotine gum, Zyban, in-person counseling, telephone counseling, using a web-based or app-based cessation program * no prior participation in one of the investigator's prior smoking cessation studies, * comfortable reading, writing, and speaking English * agree to the conditions of compensation * not currently incarcerated in a prison * willing to use the MyWebQuit program, complete study assessments, and sign an online consent form * no other member of their same household participating in the study

Design outcomes

Primary

MeasureTime frameDescription
Website Utilization3 monthsTotal website logins
Acceptability of intervention and Phase 2 engagement components3 monthsTreatment satisfaction ratings of the Phase 2 treatment conditions
Utilization of interactive messages3 monthsProportion of interactive text message prompts participants respond to
Utilization of Phase 1 text messages3 monthsProportion of participants who unsubscribe from the Phase 1 text messages
RecruitmentRecruitmentNumber of individuals screened, eligible, consented; reasons for ineligibility
Data retention3 monthsPercentage of participants who complete outcome assessment at 3-months
Acceptability of intervention and Phase 1 engagement components3 monthsTreatment satisfaction ratings of the Phase 1 treatment conditions.

Secondary

MeasureTime frameDescription
Self-reported 30-day point prevalence abstinence3 monthsPreliminary efficacy for smoking cessation
Biochemically confirmed smoking abstinence3 monthsPreliminary efficacy for smoking cessation
Self-reported 7-day point prevalence abstinence3 monthsPreliminary efficacy for smoking cessation

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026